HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
SCIO-469
Description
SCIO-469 is the first-generation oral p38 MAP kinase inhibitor developed by Scios. It has shown to be effective to cure inflammatory diseases such as Rheumatoid Arthritis.
No brand information found.
